Li Xuelu, Wang Yitong, Pan Bo, Li Man, Gao Jiyue, Zhao Yi, Zhao Zuowei
Department of Oncology & Breast Surgery, the Second Hospital of Dalian Medical University, Dalian 116023, China.
Department of Oncology, Shengjing Hospital of China Medical University, Shenyang 110004, China.
Chin J Cancer Res. 2021 Feb 28;33(1):27-32. doi: 10.21147/j.issn.1000-9604.2021.01.03.
To investigate the clinical characteristics and clinicopathological correlations of bilateral breast cancer (BBC) in China.
Data of 440 patients diagnosed with BBC in 2018 were collected from 33 centers of the Chinese Society of Breast Surgery. Demographic characteristics, bilateral tumor characteristics, and comprehensive treatment data were obtained. Correlations between the clinicopathological characteristics of bilateral tumors were analyzed.
The proportion of BBC was 0.22%-3.08%. A total of 33 (7.5%) patients had a family history of malignant tumors, 304 (69.1%) patients had synchronous BBC. Only 1 (0.2%) patient was male. More than half of all patients received concurrent or asynchronous endocrine/chemotherapy, 32.5% of all human epidermal growth factor receptor 2 (HER2)-positive patients received HER2-targeted therapy, and approximately 21.6% of all patients received radiotherapy. The most common pathological cancer type was invasive ductal cancer (>60%). Approximately 70% of all patients had bilateral hormone receptor (HR)-positive tumors and presented with a single breast mass. Significant correlations were found with pathological type, histological grade, locations of tumor, molecular subtype, Ki-67 index, tumor site and size of bilateral tumors. Results of the subgroup analysis showed more clinicopathological characteristics when synchronous BBC was compared with metachronous BBC.
In China, the clinicopathological characteristics of bilateral tumors showed significant correlations, and more significant clinicopathological correlations were observed when synchronous BBC was compared with metachronous BBC.
探讨中国双侧乳腺癌(BBC)的临床特征及临床病理相关性。
收集2018年中国乳腺外科学会33个中心诊断为BBC的440例患者的数据。获取人口统计学特征、双侧肿瘤特征及综合治疗数据。分析双侧肿瘤临床病理特征之间的相关性。
BBC的比例为0.22% - 3.08%。共有33例(7.5%)患者有恶性肿瘤家族史,304例(69.1%)患者为同步性BBC。仅1例(0.2%)患者为男性。超过半数的患者接受了同步或异时内分泌/化疗,所有人类表皮生长因子受体2(HER2)阳性患者中有32.5%接受了HER2靶向治疗,约21.6%的患者接受了放疗。最常见的病理癌症类型为浸润性导管癌(>60%)。所有患者中约70%双侧激素受体(HR)阳性肿瘤且表现为单侧乳腺肿块。发现与病理类型、组织学分级、肿瘤位置、分子亚型、Ki-67指数、双侧肿瘤的部位及大小存在显著相关性。亚组分析结果显示,同步性BBC与异时性BBC相比,具有更多的临床病理特征。
在中国,双侧肿瘤的临床病理特征显示出显著相关性,同步性BBC与异时性BBC相比,观察到更显著的临床病理相关性。